Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP685399.RAUrFFI-LGXiCMAbfbD9lBjkJfPPO_1l5IbRBC4yPXFws130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP685399.RAUrFFI-LGXiCMAbfbD9lBjkJfPPO_1l5IbRBC4yPXFws130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP685399.RAUrFFI-LGXiCMAbfbD9lBjkJfPPO_1l5IbRBC4yPXFws130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP685399.RAUrFFI-LGXiCMAbfbD9lBjkJfPPO_1l5IbRBC4yPXFws130_provenance.
- NP685399.RAUrFFI-LGXiCMAbfbD9lBjkJfPPO_1l5IbRBC4yPXFws130_assertion description "[Of additional interest, we observed that the various colon cancer cell lines in general appear to express higher levels of cyclin B1 and also display higher sensitivity to Chk1 inhibitors, implying that Chk1 inhibitor may be more efficacious in treating colon cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685399.RAUrFFI-LGXiCMAbfbD9lBjkJfPPO_1l5IbRBC4yPXFws130_provenance.
- NP685399.RAUrFFI-LGXiCMAbfbD9lBjkJfPPO_1l5IbRBC4yPXFws130_assertion evidence source_evidence_literature NP685399.RAUrFFI-LGXiCMAbfbD9lBjkJfPPO_1l5IbRBC4yPXFws130_provenance.
- NP685399.RAUrFFI-LGXiCMAbfbD9lBjkJfPPO_1l5IbRBC4yPXFws130_assertion SIO_000772 18671143 NP685399.RAUrFFI-LGXiCMAbfbD9lBjkJfPPO_1l5IbRBC4yPXFws130_provenance.
- NP685399.RAUrFFI-LGXiCMAbfbD9lBjkJfPPO_1l5IbRBC4yPXFws130_assertion wasDerivedFrom befree-2016 NP685399.RAUrFFI-LGXiCMAbfbD9lBjkJfPPO_1l5IbRBC4yPXFws130_provenance.
- NP685399.RAUrFFI-LGXiCMAbfbD9lBjkJfPPO_1l5IbRBC4yPXFws130_assertion wasGeneratedBy ECO_0000203 NP685399.RAUrFFI-LGXiCMAbfbD9lBjkJfPPO_1l5IbRBC4yPXFws130_provenance.
- befree-2016 importedOn "2016-02-19" NP685399.RAUrFFI-LGXiCMAbfbD9lBjkJfPPO_1l5IbRBC4yPXFws130_provenance.